Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 11Gynecologic 4Genitourinary 3Dermatologic 2CNS 1

Conditions

Wilms Tumor 2Testicular Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 191Gemcitabine 148Prednisone 142pembrolizumab 125enzalutamide 119Abiraterone Acetate 108Nivolumab 107Cisplatin 103Magnetic Resonance Spectroscopy 100Radiotherapy 95Sunitinib 94Leuprolide 91Carboplatin 82Specimen Handling 71Androgen Antagonists 63bicalutamide 60Radiosurgery 60Paclitaxel 59Goserelin 59Ipilimumab 57Bevacizumab 57apalutamide 53Sorafenib 53acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 51Everolimus 49cabozantinib 48abiraterone 46atezolizumab 45cabazitaxel 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Dactinomycin × Genitourinary × Clear all
NCT06309732 2024-03-13

GAMEC-II

Queen Mary University of London

Phase 2 Completed
36 enrolled
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT00335556 2017-07-21

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Children's Oncology Group

Phase 2 Completed
291 enrolled 18 charts
Genitourinary

Carcinoma, Renal Cell, Wilms Tumor

NCT00025103 2013-08-02

Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney

National Cancer Institute (NCI)

Phase 2 Unknown
75 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡